Digitisation | August 10, 2021
Fulgent Genetics and Helio Health partners to commercialize early cancer detection tests
Partnership enables broad reach of cfDNA methylation blood tests for early cancer detection
Partnership enables broad reach of cfDNA methylation blood tests for early cancer detection
Phase II trial will evaluate the safety and efficacy of ASC40 in patients with moderate to severe acne
Both companies aim to improve the efficiency and success rate of the current drug discovery process.
Nexviazyme specifically targets the M6P receptor, the key pathway for enzyme replacement therapy, to effectively clear glycogen build-up in muscle cells
Sickle Cell Disease Support Corner developed to create a database of individuals with sickle cell disease
India is dependent upon China and other countries for a lot of Key Starting Materials (KSM) for their bulk drug needs.
Centre at Sree Chitra Tirunal Institute for Medical Sciences and Technology
MitraClip implants give a new lease of life for frail and elderly patients who cannot go in for conventional open-heart surgery
The data should be submitted by August 12th 2021
Startup receives US $ 5 million in first round of funding
Subscribe To Our Newsletter & Stay Updated
